Regeneron Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING CANCER

Last updated:

Abstract:

Disclosed are compositions and methods for targeted treatment of cancer. The present disclosure provides chimeric antigen receptors and cells expressing such chimeric antigen receptors. In certain embodiments, engineered cells expressing the chimeric antigen receptors are specific for a low density cancer antigen or peptide in groove antigen.

Status:
Application
Type:

Utility

Filling date:

4 May 2021

Issue date:

3 Feb 2022